(847) 562-5868Toll Free: (855) TMS-MIND or (855) 867-6463
News

Leading National TMS provider—more locations, more doctors, more experience, more success!
Nov 08

The National Institute of Mental Health is currently recruiting participants for a clinical study to see if using functional magnetic resonance imaging (fMRI) to guide repetitive transcranial magnetic stimulation (rTMS) helps locate the best area for treatment and to explore whether the efficacy of such treatment can enhanced through cognitive behavioral therapy (CBT). Eligible participants are adults ages 18 to 65 with a major depressive disorder and current depression. The study is composed of three phases: Phase 1 will be 4 visits in 1 week where the fMRI will be done along with certain brain activity testing; Phase 2 will be conducted over 6 – 7 weeks where participants will do 30 TMS sessions combined with computer generated CBT and repeat the Phase 1 tests; and, Phase 3 will be 3 visits over three months to rate participants’ depression symptoms. A complete description of the study can be found at clinicaltrials.gov.


Nov 08

Low Level Light (or Laser) Therapy, also sometimes referred to as “Phototherapy”, was the subject of a recent study that sought to compare the effects of red and infrared LLLT on skeletal muscle fatigue in humans. A randomized double-blind placebo-controlled crossover trial was performed on 10 healthy male volunteers. They were treated with active red LLLT (660nm) and active infrared LLLT (830nm) or an identical placebo at identical locations before exercise. The study concluded that both red LLLT and infrared LLLT therapy were significantly better in delaying muscle fatigue than placebo and, further, that there was no significant difference in result between the two active LLLT therapies. A full discussion of the study parameters and results can be found at www.ncbi.nlm.nih.gov.


Nov 08

Hyperbaric Oxygen Therapy (HBOT) was recently used in combination with metabolically supported chemotherapy (MSCT), ketogenic diet (KD) and hyperthermia (HT) to treat a 29-year old patient with Stage IV Triple-Negative Breast Cancer (TNBC). The patient was admitted to the hospital in Istanbul, Turkey in October, 2016, where a whole body PET-CT scan revealed a primary tumor in her left breast, multiple left pectoral and axillary lymph nodes, multiple widespread liver masses, and an upper left nodular abdominal lesion. Following a treatment protocol consisting of MSCT, KD HT and HBOT, a follow-up full body PET-CT scan in February, 2017 showed a complete therapeutic response with no evidence of abnormal FDG uptake. The treatment protocol above was continued until April, 2017 when the patient underwent a mastectomy which revealed a complete pathological response consistent with the PET-CT scan imaging. The complete report can be seen at: www.ncbi.nlm.nih.gov.


Jun 19
post by: curtisadmin | TMS
New rTMS Study with Westmont College

On June 12, 2017,  TheraMind Center of Santa Barbara announced our role in a collaborative clinical research project with Westmont College.  This Independent Review Board (IRB) approved study, under the direction of Westmont’s neuropsychopharmacologist, Dr. Ronald See, aims to evaluate the proportional levels of certain salivary substrates throughout a typical course of repetitive Transcranial Magnetic Stimulation (rTMS), one of the primary treatment modalities used at our Center.   Despite rapid advances in rTMS as a viable therapy for drug-resistant Major Depressive Disorder (MDD), understanding of the fundamental biomechanisms of rTMS and its key clinical effects are limited.   The physiological measures which are the subjects of this clinical study have been shown to be linked to affective regulation, stress-responses, and autonomic nervous system activity.  Previous studies have sought unsuccessfully to establish reliable biomarkers for the identification of neurobiological correlates of rTMS administration.  The study being sponsored by Westmont College and the TheraMind Center of Santa Barbara hypothesizes that these salivary substrates may act as reliable biomarkers for repetitive transcranial magnetic stimulation rTMS treatment outcomes.  If proven, the study will be a significant tool for clinicians in their efforts to effectively treat patients suffering from depression.

The TheraMind Center of Santa Barbara is a unique outpatient clinic providing a combination of advanced diagnostic and neuroimaging technologies, cutting edge neuromodulation technologies including rTMS, hyperbaric oxygen therapy (HBOT), low level light therapy and PEMF, as well as body-based services. Our board certified and licensed medical professionals promote mental and neurological health through an integrative model designing individual treatment protocols for our patients. We work collaboratively as mutual referrals and adjuncts to local medical professionals for the greatest benefit to our patients. We service four primary demographics: (1) those suffering from depression, anxiety, OCD, PTSD and other mood disorders, (2) chronic pain and migraines, (3) traumatic brain injury and concussion, and (4) stroke.

For questions regarding our collaborative project or to make an appointment, please contact us via phone at (805)-845-4455 or via email at beusebio@tmsmind.com.  We are enthusiastic about discussing the details of this study, the research behind it, referrals for patients / participants, or any other pertinent matters.


Apr 03

Transcranial magnetic stimulations (TMS) is featured in this month’s Oprah “O” Magazine titled, “A Twinge of Relief”. The article notes the 2008 FDA approval of TMS for mildly treatment-resistant depression and outlines standard treatment information by Dr. Stephen Taylor, MD and professor of psychiatry at the University of Michigan.

Dr. Taylor describes a typical therapy treatment by stating that “magnetic coils are placed on one side of the patient’s head to induce electrical currents that cause neurons to discharge—delivering pure energy into the brain.” He highlighted that therapy typically involves four to six weeks of 30- to 40-minute sessions administered five times a week in a doctor’s office. The positive, he mentions, is that TMS can be as effective as taking antidepressants but with fewer side effects. Dr. Taylor closes by stating, “the idea that we’re able to ameliorate depression with a magnet is a pretty cool thing.”


Jun 10

With May being Depression Awareness month, Greatday Houston, a daily KHOU talk show, featured NeuroStar TMS Depression Therapy on their May 18, 2015 Medical Monday series. Guests included Dr. Cathy Hart, Medical Director of a local TMS Therapy Center, and a Greatday Houston viewer who had tried this new depression treatment. Dr. Hart explained how magnetic therapy works, a no pills and no surgery depression treatment, while the guest explained her struggles with depression and her TMS Therapy success story. View the show.


May 14
post by: Christine Rawlings | TMS
TMS—A New Technology is Zapping Depression

This month, Fox 40, WFTX-TV in Fort Myers, Florida featured special news coverage on TMS therapy and one women’s life changing experience. The special report was called “Latest Technology ‘Zaps’ Depression”. Diagnosed at 13 with medical depression, Jessica felt isolated, constant sadness and contemplated suicide. She wanted to share her story of struggle and success to hopefully inspire others. After the day-to-day struggles and trying so many different medications, her doctor felt she was a good candidate for TMS therapy. Jessica mentioned that the beauty of the treatment was that it didn’t hurt, there were no side affects and it truly changed her life. Read or listen to her story.


Feb 28

NewsChannel 3 in Virginia recently featured a medical segment on treating depression without drugs. The special, “Can Depression Be Treated Without Drugs?” documented a 35-year old patient and local newspaper reporter from Peninsula who suffered from depression most of her adult life, including battles with social anxiety, phobia and paranioa. Finally, she discovered a doctor in Virginia Beach who was using TMS therapy. After six weeks of weekly treatments, she was able to get back to her normal life and do one of her favorite things again, writing. Read or listen to the whole story.


Jan 16

WOSU, an Ohio State University radio station, recently featured Transcranial Magnetic Stimulation, TMS, as a new depression treatment option that is showing success among some who have struggled with mental illness for years. The show and article highlights one patient’s experience with TMS therapy after suffering from depression for over 13 years. Mr. Jefferys used drug therapy and counseling for years but at one point attempted suicide. Finally, at 48, he learned about TMS therapy. Read or listen to his TMS success story.


Jan 04

Transcranial Magnetic Stimulation therapy continues to receive great media exposure as more and more success stories are shared. A recent December 15, 2014 Us News and World Report article detailed one patient’s success story and how transcranial magnetic stimulation, or TMS, saved her life. The article also describes the origin of TMS, how TMS is different from other brain-stimulation therapies, what the treatment is like, possible side effects and those most suited for this type of depression treatment. Read the article.


Oct 15

A machine that sends magnetic pulses into a patient’s brain has become the new frontier of depression treatment, promising to ease symptoms for those who have found little relief from medication or talk therapy. The treatment, known as transcranial magnetic stimulation, or TMS, is part of a wave of technologies that attempt to jolt the brain back to health. It caught on quickly after the Food and Drug Administration approved its use six years ago, and more than 25 Chicago-area hospitals and psychiatrists now use TMS devices. Read the article.


Oct 07

An estimated 16 million people in this country are treated for depression every year. That number doesn’t count people who haven’t yet sought help. In many cases, medication is an effective way to get some relief, but there’s another, newer way some doctors are trying. Lorraine, of West Pittston, who didn’t want to share her last name, said she has battled depression for many years. Learn more by watching the video.


Sep 29

In December of 2012, Stephanie S. was taking 300 mgs of sertraline (Zoloft), 300 mgs of (bupropion Hcl) Wellbutrin, 300 mgs of trazodone hydrochloride (Desyrel), 200 mgs of risperidone (Risperdal), and 8 mgs of alprazolam (Xanax), but was as depressed as she has ever been. She had also gained 100 pounds as a side effect of all the medications. Having tried a total of 10 different kinds of drugs with no success, her doctor recommended transcranial magnetic stimulation (TMS), a non-invasive procedure that stimulates nerve cells in the brain with short magnetic pulses. A large electromagnetic coil is placed against the scalp which generates focused pulses that pass through the skull and stimulate the cerebral cortex of the brain, a region that regulates mood. The procedure was approved by the FDA in 2008.

She didn’t feel any difference after 11 treatments, but she can vividly remember the morning after her 12th treatment. She explained:

I woke up… I mean WOKE UP!! I felt so light, instead of feeling weighed down. The sun was brighter. My overall feeling was JOY. This was unfamiliar to me, and I loved it. I came downstairs grinning from ear to ear and just looked at my husband. He knew! I just threw my arms around his neck and laughed. The feeling was indescribable. It was NIRVANA!! I felt better than I had felt before my breakdown. It was MAGICAL! I think that was the first time in my life that I felt pure joy!

(more…)


1 2 3 5